CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED) - USD ($) $ in Thousands		3 Months Ended			6 Months Ended
		Jun. 30, 2022	Jun. 30, 2021		Jun. 30, 2022	Jun. 30, 2021
Operating expenses:
Research and development	[1]	$ 37,129	$ 35,067		$ 129,164	$ 69,204
Acquired in-process research and development			2,500	[2]		3,500	[2]
Selling, general and administrative		14,620	7,124		23,324	10,695
Total operating expenses		51,749	44,691		152,488	83,399
Loss from operations		(51,749)	(44,691)		(152,488)	(83,399)
Other income (expense):
Other income (expense), net		759	18		832	26
Total other income (expense), net		759	18		832	26
Net loss		(50,990)	(44,673)		(151,656)	(83,373)
Other comprehensive income (loss)
Unrealized gain on available-for-sale securities, net of tax			0		8
Comprehensive loss		$ (50,990)	$ (44,673)		$ (151,648)	$ (83,373)
Earnings Per Share, Basic		$ (0.47)	$ (178.86)		$ (1.40)	$ (663.94)
Earnings Per Share, Diluted		$ (0.47)	$ (178.86)		$ (1.40)	$ (663.94)
Weighted Average Number of Shares Outstanding, Basic		108,166,890	249,769		108,019,051	125,574
Weighted Average Number of Shares Outstanding, Diluted		108,166,890	249,769		108,019,051	125,574

[1] Includes related-party amounts of $2,285 and $4,285 for the three and six months ended June 30, 2022, respectively,

[2] Includes no related-party amounts for both the three and six months ended June 30, 2022, and $2,500 and $3,500